Neuroprotective properties of the PrP-like Shadoo glycoprotein assessed in the middle cerebral artery occlusion model of ischemia

REFERENCES

• Carlson GA, Kingsbury DT, Goodman PA, Coleman S, Marshall ST, DeArmond S, Westaway D, Prusiner SB. Linkage of prion protein and scrapie incubation time genes. Cell 1986; 46:503-11; PMID:3015416; http://dx.doi.org/10.1016/0092-8674(86)90875-5
   PubMed Web of Science ®Google Scholar
• Moore RC, Lee IY, Silverman GL, Harrison PM, Strome R, Heinrich C, Karunaratne A, Pasternak SH, Chishti MA, Liang Y, et al. Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J Mol Biol 1999; 292:797-817; PMID:10525406; http://dx.doi.org/10.1006/jmbi.1999.3108
   PubMed Web of Science ®Google Scholar
• Premzl M, Gamulin V. Comparative genomic analysis of prion genes. BMC Genomics 2007; 8:1; PMID:17199895; http://dx.doi.org/10.1186/1471-2164-8-1
   PubMed Web of Science ®Google Scholar
• Watts JC, Drisaldi B, Ng V, Yang J, Strome B, Horne P, Sy MS, Yoong L, Young R, Mastrangelo P, et al. The CNS glycoprotein Shadoo has PrP(C)-like protective properties and displays reduced levels in prion infections. Embo J 2007; 26:4038-50; PMID:17703189; http://dx.doi.org/10.1038/sj.emboj.7601830
   PubMed Web of Science ®Google Scholar
• Kuwahara C, Takeuchi AM, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y, Saeki K, Matsumoto Y, Yokoyama T, Itohara S, et al. Prions prevent neuronal cell-line death. Nature 1999; 400:225-6; PMID:10421360; http://dx.doi.org/10.1038/22241
   PubMed Web of Science ®Google Scholar
• Watt NT, Taylor DR, Gillott A, Thomas DA, Perera WS, Hooper NM. Reactive oxygen species-mediated β-cleavage of the prion protein in the cellular response to oxidative stress. J Biol Chem 2005; 280:35914-21; PMID:16120605; http://dx.doi.org/10.1074/jbc.M507327200
   PubMed Web of Science ®Google Scholar
• Dupiereux I, Falisse-Poirrier N, Zorzi W, Watt NT, Thellin O, Zorzi D, Pierard O, Hooper NM, Heinen E, Elmoualij B. Protective effect of prion protein via the N-terminal region in mediating a protective effect on paraquat-induced oxidative injury in neuronal cells. J Neurosci Res 2008; 86:653-9; PMID:17896796; http://dx.doi.org/10.1002/jnr.21506
   PubMed Web of Science ®Google Scholar
• Haigh CL, Brown DR. Prion protein reduces both oxidative and non-oxidative copper toxicity. J Neurochem 2006; 98:677-89; PMID:16787422; http://dx.doi.org/10.1111/j.1471-4159.2006.03906.x
   PubMed Web of Science ®Google Scholar
• Chiarini LB, Freitas AR, Zanata SM, Brentani RR, Martins VR, Linden R. Cellular prion protein transduces neuroprotective signals. Embo J 2002; 21:3317-26; PMID:12093733; http://dx.doi.org/10.1093/emboj/cdf324
   PubMed Web of Science ®Google Scholar
• Zanata SM, Lopes MH, Mercadante AF, Hajj GN, Chiarini LB, Nomizo R, Freitas AR, Cabral AL, Lee KS, Juliano MA, et al. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. Embo J 2002; 21:3307-16; PMID:12093732; http://dx.doi.org/10.1093/emboj/cdf325
   PubMed Web of Science ®Google Scholar
• Rambold AS, Miesbauer M, Olschewski D, Seidel R, Riemer C, Smale L, Brumm L, Levy M, Gazit E, Oesterhelt D, et al. Green tea extracts interfere with the stress-protective activity of PrP(C) and the formation of PrP(Sc). J Neurochem 2008; 107:218-29; PMID:18691383; http://dx.doi.org/10.1111/j.1471-4159.2008.05611.x
   PubMed Web of Science ®Google Scholar
• Sakthivelu V, Seidel RP, Winklhofer KF, Tatzelt J. Conserved stress-protective activity between prion protein and shadoo. J Biol Chem 2011; 286:8901-8; PMID:21257747; http://dx.doi.org/10.1074/jbc.M110.185470
   PubMed Web of Science ®Google Scholar
• Mitteregger G, Vosko M, Krebs B, Xiang W, Kohlmannsperger V, Nolting S, Hamann GF, Kretzschmar HA. The role of the octarepeat region in neuroprotective function of the cellular prion protein. Brain Pathol 2007; 17:174-83; PMID:17388948; http://dx.doi.org/10.1111/j.1750-3639.2007.00061.x
   PubMed Web of Science ®Google Scholar
• McLennan NF, Brennan PM, McNeill A, Davies I, Fotheringham A, Rennison KA, Ritchie D, Brannan F, Head MW, Ironside JW, et al. Prion protein accumulation and neuroprotection in hypoxic brain damage. Am J Pathol 2004; 165:227-35; PMID:15215178; http://dx.doi.org/10.1016/S0002-9440(10)63291-9
   PubMed Web of Science ®Google Scholar
• Shyu WC, Lin SZ, Chiang MF, Ding DC, Li KW, Chen SF, Yang HI, Li H. Overexpression of PrPC by adenovirus-mediated gene targeting reduces ischemic injury in a stroke rat model. J Neurosci 2005; 25:8967-77; PMID:16192387; http://dx.doi.org/10.1523/JNEUROSCI.1115-05.2005
   PubMed Web of Science ®Google Scholar
• Spudich A, Frigg R, Kilic E, Kilic U, Oesch B, Raeber A, Bassetti CL, Hermann DM. Aggravation of ischemic brain injury by prion protein deficiency: Role of ERK-1/-2 and STAT-1. Neurobiol Dis 2005; 20:442-9; PMID:15893468; http://dx.doi.org/10.1016/j.nbd.2005.04.002
   PubMed Web of Science ®Google Scholar
• Weise J, Crome O, Sandau R, Schulz-Schaeffer W, Bahr M, Zerr I. Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity. Neurosci Lett 2004; 372:146-50; PMID:15531106; http://dx.doi.org/10.1016/j.neulet.2004.09.030
   PubMed Web of Science ®Google Scholar
• Weise J, Sandau R, Schwarting S, Crome O, Wrede A, Schulz-Schaeffer W, Zerr I, Bahr M. Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injury. Stroke 2006; 37:1296-300; PMID:16574930; http://dx.doi.org/10.1161/01.STR.0000217262.03192.d4
   PubMed Web of Science ®Google Scholar
• Weise J, Doeppner TR, Muller T, Wrede A, Schulz-Schaeffer W, Zerr I, Witte OW, Bahr M. Overexpression of cellular prion protein alters postischemic Erk1/2 phosphorylation but not Akt phosphorylation and protects against focal cerebral ischemia. Restor Neurol Neurosci 2008; 26:57-64; PMID:18431006
   PubMed Web of Science ®Google Scholar
• Sakurai-Yamashita Y, Sakaguchi S, Yoshikawa D, Okimura N, Masuda Y, Katamine S, Niwa M. Female-specific neuroprotection against transient brain ischemia observed in mice devoid of prion protein is abolished by ectopic expression of prion protein-like protein. Neuroscience 2005; 136:281-7; PMID:16198494; http://dx.doi.org/10.1016/j.neuroscience.2005.06.095
   PubMed Web of Science ®Google Scholar
• Daude N, Wohlgemuth S, Brown R, Pitstick R, Gapeshina H, Yang J, Carlson GA, Westaway D. Knockout of the prion protein (PrP)-like Sprn gene does not produce embryonic lethality in combination with PrPC-deficiency. Proc Natl Acad Sci U S A 2012; 109:9035-40; PMID:22619325; http://dx.doi.org/10.1073/pnas.1202130109
   PubMed Web of Science ®Google Scholar
• Kokaia Z, Lindvall O. Neurogenesis after ischaemic brain insults. Curr Opin Neurobiol 2003; 13:127-32; PMID:12593991; http://dx.doi.org/10.1016/S0959-4388(03)00017-5
   PubMed Web of Science ®Google Scholar
• Westaway D, Daude N, Wohlgemuth S, Harrison P. The PrP-Like Proteins Shadoo and Doppel. Top Curr Chem 2011; 305:225-56; PMID:21728138; http://dx.doi.org/10.1007/128_2011_190
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, et al. Heart disease and stroke statistics-2015 update: a report from the american heart association. Circulation 2015; 131:e29-e322; PMID:25520374; http://dx.doi.org/10.1161/CIR.0000000000000152
   PubMed Web of Science ®Google Scholar
• Klijn CJ, Hankey GJ. Management of acute ischaemic stroke: new guidelines from the American Stroke Association and European Stroke Initiative. Lancet Neurol 2003; 2:698-701; PMID:14572738; http://dx.doi.org/10.1016/S1474-4422(03)00558-1
   PubMed Web of Science ®Google Scholar
• Joo H, George MG, Fang J, Wang G. A literature review of indirect costs associated with stroke. J Stroke Cerebrovasc Dis 2014; 23:1753-63; PMID:24957313; http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2014.02.017
   PubMed Web of Science ®Google Scholar
• Guillot-Sestier MV, Sunyach C, Druon C, Scarzello S, Checler F. The α-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo. J Biol Chem 2009; 284:35973-86; PMID:19850936; http://dx.doi.org/10.1074/jbc.M109.051086
   PubMed Web of Science ®Google Scholar
• Beland M, Roucou X. Taking advantage of physiological proteolytic processing of the prion protein for a therapeutic perspective in prion and Alzheimer diseases. Prion 2013; 8:106-10; http://dx.doi.org/10.4161/pri.27438
   Web of Science ®Google Scholar
• Mitsios N, Saka M, Krupinski J, Pennucci R, Sanfeliu C, Miguel Turu M, Gaffney J, Kumar P, Kumar S, Sullivan M, et al. Cellular prion protein is increased in the plasma and peri-infarcted brain tissue after acute stroke. J Neurosci Res 2007; 85:602-11; PMID:17149767; http://dx.doi.org/10.1002/jnr.21142
   PubMed Web of Science ®Google Scholar
• Premzl M, Sangiorgio L, Strumbo B, Marshall Graves JA, Simonic T, Gready JE. Shadoo, a new protein highly conserved from fish to mammals and with similarity to prion protein. Gene 2003; 314:89-102; PMID:14527721; http://dx.doi.org/10.1016/S0378-1119(03)00707-8
   PubMed Web of Science ®Google Scholar
• Watts JC, Westaway D. The prion protein family: Diversity, rivalry, and dysfunction. Biochim Biophys Acta 2007; 1772:654-72; PMID:17562432; http://dx.doi.org/10.1016/j.bbadis.2007.05.001
   PubMed Web of Science ®Google Scholar
• Watts JC, Huo H, Bai Y, Ehsani S, Won AH, Shi T, Daude N, Lau A, Young R, Xu L, et al. Interactome analyses identify ties of PrP and its mammalian paralogs to oligomannosidic N-glycans and endoplasmic reticulum-derived chaperones. PLoS Pathog 2009; 5:e1000608; PMID:19798432; http://dx.doi.org/10.1371/journal.ppat.1000608
   PubMed Web of Science ®Google Scholar
• Culmsee C, Zhu C, Landshamer S, Becattini B, Wagner E, Pellecchia M, Blomgren K, Plesnila N. Apoptosis-inducing factor triggered by poly(ADP-ribose) polymerase and Bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia. J Neurosci 2005; 25:10262-72; PMID:16267234; http://dx.doi.org/10.1523/JNEUROSCI.2818-05.2005
   PubMed Web of Science ®Google Scholar
• Li Y, Yu SP, Mohamad O, Genetta T, Wei L. Sublethal transient global ischemia stimulates migration of neuroblasts and neurogenesis in mice. Transl Stroke Res 2010; 1:184-96; PMID:21792374; http://dx.doi.org/10.1007/s12975-010-0016-6
   PubMed Web of Science ®Google Scholar
• Carmichael ST. Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx 2005; 2:396-409; PMID:16389304; http://dx.doi.org/10.1602/neurorx.2.3.396
   PubMedGoogle Scholar
• Lau A, Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch 2010; 460:525-42; PMID:20229265; http://dx.doi.org/10.1007/s00424-010-0809-1
   PubMed Web of Science ®Google Scholar
• Khosravani H, Zhang Y, Tsutsui S, Hameed S, Altier C, Hamid J, Chen L, Villemaire M, Ali Z, Jirik FR, et al. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Cell Biol 2008; 181:551-65; PMID:18443219; http://dx.doi.org/10.1083/jcb.20-0711002
   PubMed Web of Science ®Google Scholar
• Ciric D, Richard CA, Moudjou M, Chapuis J, Sibille P, Daude N, Westaway D, Adrover M, Beringue V, Martin D, et al. Interaction between Shadoo and PrP Affects the PrP-Folding Pathway. J Virol 2015; 89:6287-93; PMID:25855735; http://dx.doi.org/10.1128/JVI.03429-14
   PubMed Web of Science ®Google Scholar
• Drisaldi B, Stewart RS, Adles C, Stewart LR, Quaglio E, Biasini E, Fioriti L, Chiesa R, Harris DA. Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J Biol Chem 2003; 278:21732-43; PMID:12663673; http://dx.doi.org/10.1074/jbc.M213247200
   PubMed Web of Science ®Google Scholar
• Westaway D, Genovesi S, Daude N, Brown R, Lau A, Lee I, Mays CE, Coomaraswamy J, Canine B, Pitstick R, et al. Downregulation of Shadoo in prion infections traces a pre-clinical event inversely related to PrP(Sc) accumulation. PLoS Pathog 2011; 7:e1002391
   PubMed Web of Science ®Google Scholar
• Safar JG, DeArmond SJ, Kociuba K, Deering C, Didorenko S, Bouzamondo-Bernstein E, Prusiner SB, Tremblay P. Prion clearance in bigenic mice. J Gen Virol 2005; 86:2913-23; PMID:16186247; http://dx.doi.org/10.1099/vir.0.80947-0
   PubMed Web of Science ®Google Scholar
• Watts JC, Stohr J, Bhardwaj S, Wille H, Oehler A, Dearmond SJ, Giles K, Prusiner SB. Protease-resistant prions selectively decrease shadoo protein. PLoS Pathog 2011; 7:e1002382; PMID:22163178; http://dx.doi.org/10.1371/journal.ppat.1002382
   PubMed Web of Science ®Google Scholar
• Mays CE, Kim C, Haldiman T, van der Merwe J, Lau A, Yang J, Grams J, Di Bari MA, Nonno R, Telling GC, et al. Prion disease tempo determined by host-dependent substrate reduction. J Clin Invest 2014; 124:847-58; PMID:24430187; http://dx.doi.org/10.1172/JCI72241
   PubMed Web of Science ®Google Scholar
• Lau A, Mays CE, Genovesi S, Westaway D. RGG Repeats of PrP-like Shadoo Protein Bind Nucleic Acids. Biochemistry 2012; 51:9029-31; PMID:23121093; http://dx.doi.org/10.1021/bi3013-95w
   PubMed Web of Science ®Google Scholar
• Mays CE, Coomaraswamy J, Watts JC, Yang J, Ko KW, Strome B, Mercer RC, Wohlgemuth SL, Schmitt-Ulms G, Westaway D. Endoproteolytic Processing of the Mammalian Prion Glycoprotein Family. FEBS J 2014; 281:862-76; PMID:24286250; http://dx.doi.org/10.1111/febs.12654
   PubMed Web of Science ®Google Scholar
• Liang J, Kong Q. α-Cleavage of cellular prion protein. Prion 2012; 6:453-60; PMID:23052041; http://dx.doi.org/10.4161/pri.22511
   PubMed Web of Science ®Google Scholar
• Lau A, McDonald A, Daude N, Mays CE, Walter ED, Aglietti R, Mercer RC, Wohlgemuth S, van der Merwe J, Yang J, et al. Octarepeat region flexibility impacts prion function, endoproteolysis and disease manifestation. EMBO Mol Med 2015; 7(3):339-56
   PubMed Web of Science ®Google Scholar
• Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9:671-5; PMID:22930834; http://dx.doi.org/10.1038/nmeth.2089
   PubMed Web of Science ®Google Scholar
• Tsuchiya D, Hong S, Kayama T, Panter SS, Weinstein PR. Effect of suture size and carotid clip application upon blood flow and infarct volume after permanent and temporary middle cerebral artery occlusion in mice. Brain Res 2003; 970:131-9; PMID:12706254; http://dx.doi.org/10.1016/S0006-8993(03)02300-X
   PubMed Web of Science ®Google Scholar